Current pharmacotherapautic options for children with attention deficit hyperactivity disorders and comorbidities: A general pediatrics perspetive

14th World Congress on General Pediatrics & Adolescent medicine
September 25-27, 2017 Chicago, USA

Abiodun A Oyebola

Back2Play Pediatrics, Canada

Keynote: Ped Health Res

DOI: 10.21767/2574-2817-C1-001


Attention Deficit Hyperactivity Disorder is probably the most common neurodevelopmental problem encoutered in children. These kids will present with inattention or difficulty with focus and hyperactivity. As a result, the family doctor and the general pediatrician are the first line of contact for the parent seeking assistance. While monotherapy is effective in treating ADHD, there are common co-morbidites associated with ADHD such as anxiety/depression, learning disorders, tourettes disorder, substance abuse and oppostional defiant disorder. Failure to treat these disorders will lead to poor outcomes in these group of children. This oral presentation will discuss monotherapy vs. combination therapy, treatment options available for the general pediatrician/family doctor in treatment of ADHD and co-morbidities.


Abiodun A Oyebola has completed his Medical degree in Nigeria. He has obtained his Master’s degree in Public Health (Child and Maternal Health) in USA shortly after leaving medical school. He did his Pediatric Training at the John H Stroger Hosptial of Cook Country in Chicago. He is Board Certified by the American Board of Pediatrics. With over 15 years of experience and wealth of wisdom in the care of children, he is a passionate Advocate for kids and this shows in his expert administration of care to his ever growing patient family. He has become one of the top rated Paediatricians in the Greater Hamilton Area.